IBDEI175 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20345,0)
 ;;=B97.89^^84^931^89
 ;;^UTILITY(U,$J,358.3,20345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20345,1,3,0)
 ;;=3^Viral Agent Cause of Disease
 ;;^UTILITY(U,$J,358.3,20345,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,20345,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,20346,0)
 ;;=B97.10^^84^931^21
 ;;^UTILITY(U,$J,358.3,20346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20346,1,3,0)
 ;;=3^Enterovirus Cause of Disease
 ;;^UTILITY(U,$J,358.3,20346,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,20346,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,20347,0)
 ;;=B34.9^^84^931^90
 ;;^UTILITY(U,$J,358.3,20347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20347,1,3,0)
 ;;=3^Viral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,20347,1,4,0)
 ;;=4^B34.9
 ;;^UTILITY(U,$J,358.3,20347,2)
 ;;=^5000603
 ;;^UTILITY(U,$J,358.3,20348,0)
 ;;=A69.20^^84^931^50
 ;;^UTILITY(U,$J,358.3,20348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20348,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,20348,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,20348,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,20349,0)
 ;;=A69.22^^84^931^52
 ;;^UTILITY(U,$J,358.3,20349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20349,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,20349,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,20349,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,20350,0)
 ;;=A69.21^^84^931^51
 ;;^UTILITY(U,$J,358.3,20350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20350,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,20350,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,20350,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,20351,0)
 ;;=A69.29^^84^931^18
 ;;^UTILITY(U,$J,358.3,20351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20351,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,20351,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,20351,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,20352,0)
 ;;=A69.23^^84^931^5
 ;;^UTILITY(U,$J,358.3,20352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20352,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,20352,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,20352,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,20353,0)
 ;;=A51.0^^84^931^29
 ;;^UTILITY(U,$J,358.3,20353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20353,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,20353,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,20353,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,20354,0)
 ;;=A52.3^^84^931^54
 ;;^UTILITY(U,$J,358.3,20354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20354,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,20354,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,20354,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,20355,0)
 ;;=A52.10^^84^931^53
 ;;^UTILITY(U,$J,358.3,20355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20355,1,3,0)
 ;;=3^Neurosyphilis Symptomatic,Unspec
 ;;^UTILITY(U,$J,358.3,20355,1,4,0)
 ;;=4^A52.10
 ;;^UTILITY(U,$J,358.3,20355,2)
 ;;=^5000291
 ;;^UTILITY(U,$J,358.3,20356,0)
 ;;=A52.9^^84^931^49
 ;;^UTILITY(U,$J,358.3,20356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20356,1,3,0)
 ;;=3^Late Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,20356,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,20356,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,20357,0)
 ;;=A53.9^^84^931^79
 ;;^UTILITY(U,$J,358.3,20357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20357,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,20357,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,20357,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,20358,0)
 ;;=B37.3^^84^931^17
 ;;^UTILITY(U,$J,358.3,20358,1,0)
 ;;=^358.31IA^4^2
